-
Mashup Score: 18Prehabilitation for Patients with Cancer Undergoing Radiation Therapy: a Scoping Review - 3 day(s) ago
Prehabilitation is a process of identifying and assessing factors that could compromise the physical and psychological health of patients undergoing cancer treatment and implementing an intervention to combat such concerns. The use of prehabilitation in cancer surgery has yielded positive outcomes in rectal, lung and abdominal cancers. Prehabilitation strategies have potential to improve the management of patients receiving radiation therapy or chemoradiation. The aim of the present study was to map the evidence of the assessment and evaluation of prehabilitation for radiation therapy patients.
Source: www.clinicaloncologyonline.netCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 41Returning to work after cancer | Support and resources - 8 day(s) ago
If you are thinking about going back to work after cancer treatment, we have information about how to manage the transition and getting employer support.
Source: www.macmillan.org.ukCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 4
The combination of trastuzumab and pertuzumab (HP) as part of a taxane-based regimen has shown benefit in the adjuvant and metastatic HER2+ breast cancer setting. In the CLEOPATRA trial, pruritus was reported in 11-17.6% of patients. The clinical phenotype …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 21Pilot Randomized Controlled Trial of an Educational Video for CAR T-Cell Therapy Recipients - 21 day(s) ago
Background: CAR T-cell therapy has transformed the treatment of hematologic malignancies, but it is complex and challenging to convey to patients. Educational video interventions are efficacious for improving patient knowledge about cancer therapeutics and informing their care preferences, yet no educational videos have been evaluated in CAR T-cell therapy. Methods: We conducted a randomized controlled trial comparing an educational video versus usual care in adults (age ≥18 years) with hematologic malignancies receiving CAR T-cell therapy at Massachusetts General Hospital. Intervention participants watched a 13-minute video depicting how CAR T-cell therapy works, logistics, toxicities, prognosis, recovery, and approaches for dealing with prognostic uncertainty. The primary outcome was feasibility (≥60% enrollment rate). Secondary outcomes included acceptability (≥80% reporting comfort with the video), patients’ knowledge about CAR T-cell therapy (10-item test), and self-efficacy (Comm
Source: jnccn.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 5Hot Topics, Challenges & Opportunities in Cancer & Palliative Care Psychology | BPS - 1 month(s) ago
Drop in to a day of bize-size 20 minute update sessions on a range of topics across cancer and palliative care psychology.
Source: www.bps.org.ukCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 12Fill | Macmillan Best Practice Webinar: Sex and Cancer - 2 month(s) ago
Please fill out the form below to register for the Sex and Cancer Webinar. We will send you a link to join 48 hours prior to the start. This webinar is sponsored by Lovehoney.
Source: forms.office.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 4Why women's health matters and how we can do better - 2 month(s) ago
Read the first blog from our International Women’s Day series exploring issues in women’s health and what this means for cancer.
Source: www.macmillan.org.ukCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 0
The quality statement describes what good quality palliative and end of life care services should look like.
Source: www.gov.walesCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 0Research portfolio - 2 month(s) ago
Our research portfolio spans a range of methodologies and types of research.
Source: www.cardiff.ac.ukCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 34Will cancer ever be cured? - 4 month(s) ago
As we continue to look at what Macmillan’s place will be in health and cancer care in the future, Dr Richard Simcock explores one of the biggest questions of all.
Source: www.macmillan.org.ukCategories: General Medicine News, Oncologists2Tweet
A helpful scoping review on #prehab in #radonc from @lauremarignol Heterogeneity (diseases, interventions and outcome assessments) a problem in the evidence but enough signal in the noise to keep pushing. Free full text https://t.co/hlInvJXWdL https://t.co/XvihAaRkLq